SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001169245-22-000013
Filing Date
2022-02-28
Accepted
2022-02-28 19:25:12
Documents
1
Period of Report
2022-02-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_164609429220987.html 4  
1 FORM 4 wf-form4_164609429220987.xml 4 6395
  Complete submission text file 0001169245-22-000013.txt   8014
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Issuer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PHASEBIO PHARMACEUTICALS, INC. 1 GREAT VALLEY PARKWAY, SUITE 30 MALVERN PA 19355
Business Address
Birchall Jonathan (Reporting) CIK: 0001892776 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38697 | Film No.: 22692950